Form 8-K - Current report:
SEC Accession No. 0001140361-25-031374
Filing Date
2025-08-15
Accepted
2025-08-14 21:37:47
Documents
44
Period of Report
2025-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20053945_8k.htm   iXBRL 8-K 41703
2 EXHIBIT 1.1 ef20053945_ex1-1.htm EX-1.1 250463
3 EXHIBIT 5.1 ef20053945_ex5-1.htm EX-5.1 16810
4 EXHIBIT 99.1 ef20053945_ex99-1.htm EX-99.1 55498
5 EXHIBIT 99.2 ef20053945_ex99-2.htm EX-99.2 12174
9 ef20053945_ex99-1slide1.jpg GRAPHIC 156996
10 ef20053945_ex99-1slide2.jpg GRAPHIC 430856
11 ef20053945_ex99-1slide3.jpg GRAPHIC 153636
12 ef20053945_ex99-1slide4.jpg GRAPHIC 152586
13 ef20053945_ex99-1slide5.jpg GRAPHIC 174477
14 ef20053945_ex99-1slide6.jpg GRAPHIC 147992
15 ef20053945_ex99-1slide7.jpg GRAPHIC 133690
16 ef20053945_ex99-1slide8.jpg GRAPHIC 146160
17 ef20053945_ex99-1slide9.jpg GRAPHIC 63232
18 ef20053945_ex99-1slide10.jpg GRAPHIC 237641
19 ef20053945_ex99-1slide11.jpg GRAPHIC 65542
20 ef20053945_ex99-1slide12.jpg GRAPHIC 170442
21 ef20053945_ex99-1slide13.jpg GRAPHIC 143587
22 ef20053945_ex99-1slide14.jpg GRAPHIC 182600
23 ef20053945_ex99-1slide15.jpg GRAPHIC 143489
24 ef20053945_ex99-1slide16.jpg GRAPHIC 178520
25 ef20053945_ex99-1slide17.jpg GRAPHIC 177820
26 ef20053945_ex99-1slide18.jpg GRAPHIC 157309
27 ef20053945_ex99-1slide19.jpg GRAPHIC 108360
28 ef20053945_ex99-1slide20.jpg GRAPHIC 169344
29 ef20053945_ex99-1slide21.jpg GRAPHIC 47694
30 ef20053945_ex99-1slide22.jpg GRAPHIC 167333
31 ef20053945_ex99-1slide23.jpg GRAPHIC 195113
32 ef20053945_ex99-1slide24.jpg GRAPHIC 200343
33 ef20053945_ex99-1slide25.jpg GRAPHIC 90838
34 ef20053945_ex99-1slide26.jpg GRAPHIC 44428
35 image0.jpg GRAPHIC 4532
36 image00001.jpg GRAPHIC 9305
  Complete submission text file 0001140361-25-031374.txt   6176752

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aqst-20250814.xsd EX-101.SCH 3868
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20250814_lab.xml EX-101.LAB 21966
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20250814_pre.xml EX-101.PRE 16046
47 EXTRACTED XBRL INSTANCE DOCUMENT ef20053945_8k_htm.xml XML 4067
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251222221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)